Education
About Us
Working with TipRanks
Follow Us
Xeno Transplants Corporation (XENO)
OTHER OTC:XENO
XENO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.10 - $0.10
Previous CloseN/A
Volume5.00K
Average Volume (3M)0.00
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,364,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
XENO FAQ
What was Xeno Transplants Corporation’s price range in the past 12 months?
Xeno Transplants Corporation lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is Xeno Transplants Corporation’s market cap?
Currently, no data Available
When is Xeno Transplants Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Xeno Transplants Corporation’s earnings last quarter?
Currently, no data Available
Is Xeno Transplants Corporation overvalued?
According to Wall Street analysts Xeno Transplants Corporation’s price is currently Overvalued.
Does Xeno Transplants Corporation pay dividends?
Xeno Transplants Corporation does not currently pay dividends.
What is Xeno Transplants Corporation’s EPS estimate?
Xeno Transplants Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xeno Transplants Corporation have?
Xeno Transplants Corporation has 40,364,000 shares outstanding.
What happened to Xeno Transplants Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Xeno Transplants Corporation?
Currently, no hedge funds are holding shares in XENO
---
Company Description
Xeno Transplants Corporation
Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.
---
Technical Analysis
Alnylam Pharma
―
Veru
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
---